surmount-1 tirzepatide 15 mg weight loss percent reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism 🔴Tirzepatide for obesity and diabetes
Description
Users on tirzepatide sometimes maintain or even gain weight while losing inches, particularly if they are simultaneously building muscle through resistance training
Patients who maintain higher protein intake and regular resistance training during treatment tend to preserve lean muscle mass better while losing fat
GLP-1 receptor agonist 2
BGNs, bioactive glass nanoparticles
